Table 1.
Preoperative, perioperative, pathological, and postoperative characteristics of prostate cancer patients (the entire study cohort, n = 100).
Fig 1.
A: Biochemical recurrence (BCR)-free survival among prostate cancer patients in the below high-risk group (<HR) and the high-risk/very high-risk group (≥HR). B: BCR-free survival among patients in the high-risk/very high-risk group, without adjuvant treatment (≥HR without AT), and high-risk/very high-risk group, with adjuvant treatment (≥HR with AT).
Fig 2.
A: Proportion of prostate cancer patients with stress urinary incontinence (SUI) after robot-assisted radical prostatectomy over time. B: Proportion of patients with urgency urinary incontinence (UUI) after robot-assisted radical prostatectomy over time. *p < 0.05, **p < 0.01, ***p < 0.001.
Table 2.
Univariable and multivariable logistic regression models of risks of stress urinary incontinence in prostate cancer patients with functional documentation (n = 71) 1 week, 6 months, and 12 months after robot-assisted radical prostatectomy.